Key result
Mice with mutations in the Zα domain of ADAR1 spontaneously induced type I IFNs and IFN-stimulated genes in multiple organs via a MAVS-dependent pathway, improving control of influenza A virus.
Why the study?
Does the Zα domain of ADAR1 prevent aberrant interferon induction by endogenous Z-form RNAs in mice?
Does the Zα domain of ADAR1 prevent aberrant interferon induction by endogenous Z-form RNAs in mice?
The Zα domain of ADAR1 is required to prevent aberrant interferon responses triggered by endogenous Z-form RNAs.
Zα domain mutation in mice drives spontaneous IFN responses and viral control; leaves open translation to human interferonopathies or antiviral strategies.
Nucleic acids are powerful triggers of innate immunity and can adopt the unusual Z-conformation. The p150 isoform of adenosine deaminase acting on RNA 1 (ADAR1) prevents aberrant interferon (IFN) induction and contains a Z-nucleic acid binding (Z α ) domain. We report that knock-in mice bearing two point mutations in the Z α domain of ADAR1, which abolish binding to Z-form nucleic acids, spontaneously induced type I IFNs and IFN-stimulated genes (ISGs) in multiple organs. This included the lung where both stromal and haematopoietic cells displayed ISG induction in Adar1 mZα/mZα mice. Concomitantly, Adar1 mZα/mZα mice showed improved control of influenza A virus. The spontaneous IFN response in Adar1 mZα/mZα mice required MAVS, implicating cytosolic RNA sensing. Finally, analysis of A-to-I changes revealed a specific requirement of ADAR1’s Z α domain in editing of a subset of RNAs. In summary, our results reveal that endogenous RNAs in Z-conformation have immunostimulatory potential that is curtailed by ADAR1.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2020) studied Innate immunity / Interferon response. ADAR1 Zα domain mutation (Adar1mZa/mZa) vs. Wild-type mice was evaluated on Induction of type I IFNs and IFN-stimulated genes (ISGs). Mice with mutations in the Zα domain of ADAR1 spontaneously induced type I IFNs and IFN-stimulated genes in multiple organs via a MAVS-dependent pathway, improving control of influenza A virus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: